Göçeroğlu Arda, Berden Annelies E, Fiocco Marta, Floßmann Oliver, Westman Kerstin W, Ferrario Franco, Gaskin Gill, Pusey Charles D, Hagen E Christiaan, Noël Laure-Hélène, Rasmussen Niels, Waldherr Rüdiger, Walsh Michael, Bruijn Jan A, Jayne David R W, Bajema Ingeborg M
Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands.
PLoS One. 2016 Dec 14;11(12):e0165402. doi: 10.1371/journal.pone.0165402. eCollection 2016.
Relapse in ANCA-associated vasculitis (AAV) has been studied previously, but there are few studies on renal relapse in particular. Identifying patients at high risk of renal relapse may aid in optimizing clinical management. We investigated which clinical and histological parameters are risk factors for renal relapse in ANCA-associated glomerulonephritis (AAGN). Patients (n = 174) were newly diagnosed and had mild-moderate or severe renal involvement. Data were derived from two trials of the European Vasculitis Society: MEPEX and CYCAZAREM. The Cox regression model was used to identify parameters increasing the instantaneous risk (= rate) of renal relapse (useful for instant clinical decisions). For identifying predictors of renal relapse during follow-up, we used Fine & Gray's regression model. Competing events were end-stage renal failure and death. The cumulative incidence of renal relapse at 5 years was 9.5% (95% CI: 4.8-14.3%). In the Cox model, sclerotic class AAGN increased the instantaneous risk of renal relapse. In Fine & Gray's model, the absence of interstitial infiltrates at diagnosis was predictive for renal relapse. In this study we used two different models to identify possible relationships between clinical and histopathological parameters at time of diagnosis of AAV with the risk of experiencing renal relapse. Sclerotic class AAGN increased the instantaneous risk of renal relapse. This association is most likely due to the high proportion of sclerosed glomeruli reducing the compensatory capacity. The absence of interstitial infiltrates increased the risk of renal relapse which is a warning sign that patients with a relatively benign onset of disease may also be prone to renal relapse. Renal relapses occurring in patients with sclerotic class AAGN and renal relapses occurring in patients without interstitial infiltrates were mutually exclusive, which may indicate that they are essentially different.
此前已有关于抗中性粒细胞胞浆抗体相关性血管炎(AAV)复发的研究,但针对肾脏复发的研究尤其少见。识别有肾脏复发高风险的患者可能有助于优化临床管理。我们调查了哪些临床和组织学参数是抗中性粒细胞胞浆抗体相关性肾小球肾炎(AAGN)肾脏复发的危险因素。患者(n = 174)为新诊断病例,有轻度 - 中度或重度肾脏受累。数据源自欧洲血管炎学会的两项试验:MEPEX和CYCAZAREM。采用Cox回归模型来识别增加肾脏复发瞬时风险(=发生率)的参数(有助于即时临床决策)。为了识别随访期间肾脏复发的预测因素,我们使用了Fine & Gray回归模型。竞争事件为终末期肾衰竭和死亡。5年时肾脏复发的累积发生率为9.5%(95%置信区间:4.8 - 14.3%)。在Cox模型中,硬化型AAGN增加了肾脏复发的瞬时风险。在Fine & Gray模型中,诊断时无间质浸润是肾脏复发的预测因素。在本研究中,我们使用了两种不同的模型来识别AAV诊断时临床和组织病理学参数与肾脏复发风险之间的可能关系。硬化型AAGN增加了肾脏复发的瞬时风险。这种关联很可能是由于硬化肾小球比例高导致代偿能力降低。无间质浸润增加了肾脏复发风险,这是一个警示信号,表明疾病起病相对良性的患者也可能易于发生肾脏复发。硬化型AAGN患者发生的肾脏复发和无间质浸润患者发生的肾脏复发相互排斥,这可能表明它们本质上不同。